- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03583762
Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique
10. juli 2018 opdateret af: Romanee Chaiwarith, Chiang Mai University
Comparison of Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique for Identification of Positive Blood Cultures
This is an experimental study of participants who had positive blood culture to compare time to appropriate antibiotic between using Microarray Assay and Mass Spectrometry to bacterial Identification.
Studieoversigt
Status
Ukendt
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Between June to Dec 2018, 200 participants those met the eligibility criteria were enrolled in this study that is a quasi experimental study.
All participants were empirical antibiotic therapy by infectious physician.
100 patients in Pre-intervention group had bacterial identification by Mass spectrometry technique from bacterial colony and 100 patients in Post-intervention group had bacterial identification by Microarray assay from blood culture.
Antibiotic adjustment were considered after bacterial identification and result of antibiotic susceptibility testing.
Then all participants were re-evaluated outcome after treatment.
Finally, the results were ready to analysis in January 2019.
Undersøgelsestype
Interventionel
Tilmelding (Forventet)
200
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Parichart Sakulkonkij, MD
- Telefonnummer: +66-81595-8662
- E-mail: papi-jung@hotmail.com
Undersøgelse Kontakt Backup
- Navn: Parichat Salee, MD
- Telefonnummer: +66-5393-6457
- E-mail: parichat.pimsarn@gmail.com
Studiesteder
-
-
-
Chiang Mai, Thailand, 50200
- Maharaj Nakorn Chiang Mai Hospital, Department of Medicine, Chiang Mai University
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Age ≥ 18 year old with positive hemoculture between June 2018 and Dec 2018
- Internal medicine wards patients at Maharaj Nakorn Chiang Mai Hospital
- Ability to provide informed consent
Exclusion Criteria:
- Suspected contaminated positive blood culture
- Bacteremia cause by more than two species of bacteria, as suspected from the gram staining examinations
- Terminally ill patients
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Ikke-randomiseret
- Interventionel model: Sekventiel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Pre-intervention group
100 participants received empiric antibiotic by ID physician, bacterial identification by Mass spectrometry technique
|
Molecular diagnostic test for bacterial identification from bacterial colony
|
Eksperimentel: Post-intervention group
100 participants received empiric antibiotic therapy by ID physician, bacterial identification by Microarray assay from blood culture and confirm with Mass spectrometry technique
|
Bacterial identification by Microarray assay from positive blood culture and confirmed by Mass spectrometry technique from bacterial colony.
Adjusted antibiotic therapy according to AST Re-evaluation after treatment
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
To compare the time to appropriate antibiotic therapy in patients with positive blood cultures between using Microarray assays versus Mass Spectrometry technique for Identification of Positive Blood Cultures
Tidsramme: 4 days from positive hemoculture
|
Comparison of time that participants received appropriate antibiotic therapy between 2 study period (Mass spectrometry technique and Microarray assay group)
|
4 days from positive hemoculture
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Mortality rate at 2 weeks
Tidsramme: 14 days from positive hemoculture
|
To compare proportion of mortality between 2 study periods (Mass spectrometry technique and Microarray assay group) at 2 weeks after enrollment
|
14 days from positive hemoculture
|
Length of hospital stays
Tidsramme: 30 days
|
To compare lengths of hospital stay between 2 study periods (Mass spectrometry technique and Microarray assay group)
|
30 days
|
Cost of antibiotic therapy
Tidsramme: 14 days
|
To compare the cost of antibiotics for the course of treatment during study period between 2 study period (Mass spectrometry technique and Microarray assay group)
|
14 days
|
Percentage of De-escalation or escalation antibiotic
Tidsramme: 14 days
|
To compare percentage of De-escalation or escalation antibiotic between 2 study periods (Mass spectrometry technique and Microarray assay group)
|
14 days
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Parichart Sakulkonkij, MD, Chiang Mai University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Forventet)
30. juli 2018
Primær færdiggørelse (Forventet)
31. december 2018
Studieafslutning (Forventet)
31. marts 2019
Datoer for studieregistrering
Først indsendt
15. juni 2018
Først indsendt, der opfyldte QC-kriterier
10. juli 2018
Først opslået (Faktiske)
11. juli 2018
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
11. juli 2018
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
10. juli 2018
Sidst verificeret
1. juli 2018
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- MED-2561-05383
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
UBESLUTET
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Mass spectrometry
-
Fondazione Don Carlo Gnocchi OnlusMeyer Children's Hospital IRCCS; Fondazione Don Carlo Gnocchi ONLUS - Centro...Rekruttering
-
PHCC LPNational Heart, Lung, and Blood Institute (NHLBI)AfsluttetHjerte-kar-sygdommeForenede Stater
-
NuVasiveAfsluttetLumbal Degenerativ Disc SygdomForenede Stater
-
Istanbul Gelisim UniversityMarmara UniversityAfsluttetFedme | Leverfedt | FedtleversygdomKalkun
-
Baystate Medical CenterNational Institute of Mental Health (NIMH)AfsluttetAttention Deficit Disorder med hyperaktivitet
-
Marmara UniversityAfsluttetFedme | Insulin resistens | PrædiabetesKalkun
-
GI Windows, Inc.Aktiv, ikke rekrutterendeFedme | Type 2 diabetesArgentina
-
University of California, San DiegoUnited States Department of Agriculture (USDA); Latino Health Access; California... og andre samarbejdspartnereAktiv, ikke rekrutterende
-
University of MiamiNational Institute on Minority Health and Health Disparities (NIMHD)Rekruttering
-
Assiut UniversityIkke rekrutterer endnu